{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:04:26Z","timestamp":1746335066456},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,9,1]]},"DOI":"10.2169\/internalmedicine.8564-21","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T22:08:54Z","timestamp":1644271734000},"page":"2661-2666","source":"Crossref","is-referenced-by-count":3,"title":["Erdheim-Chester Disease Involving the Central Nervous System with Latent Toxoplasmosis"],"prefix":"10.2169","volume":"61","author":[{"given":"Tomoya","family":"Wadayama","sequence":"first","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikito","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikko","family":"Kimura","sequence":"additional","affiliation":[{"name":"Graduate School of Frontier Biosciences, Osaka University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goichi","family":"Beck","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Nagano","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinori","family":"Shirano","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsushi","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Osaka City General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Norose","sequence":"additional","affiliation":[{"name":"Department of Infection and Host Defense, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hikosaka","sequence":"additional","affiliation":[{"name":"Department of Infection and Host Defense, Graduate School of Medicine, Chiba University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Murayama","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Osaka University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tamura S, Kawamoto K, Miyoshi H, et al. Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: a case report. J Clin Exp Hematop 58: 161-165, 2018.","DOI":"10.3960\/jslrt.18015"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Diamond EL, Dagna L, Hyman DM, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood 124: 483-492, 2014.","DOI":"10.1182\/blood-2014-03-561381"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Goyal G, Young JR, Koster MJ, et al. The Mayo Clinic histiocytosis working group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. Mayo Clin Proc 94: 2054-2071, 2019.","DOI":"10.1016\/j.mayocp.2019.02.023"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 363: 1965-1976, 2004.","DOI":"10.1016\/S0140-6736(04)16412-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mikita K, Maeda T, Ono T, Miyahira Y, Asai T, Kawana A. The utility of cerebrospinal fluid for the molecular diagnosis of toxoplasmic encephalitis. Diagn Microbiol Infect Dis 75: 155-159, 2013.","DOI":"10.1016\/j.diagmicrobio.2012.10.015"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Loo E, Khalili P, Beuhler K, Siddiqi I, Vasef MA. BRAF V600E mutation across multiple tumor types: correlation between DNA-based sequencing and mutation-specific immunohistochemistry. Appl Immunohistochem Mol Morphol 26: 709-713, 2018.","DOI":"10.1097\/PAI.0000000000000516"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Castro KG, Ward JW, Slutsker L, et al.; National Center for Infectious Disease Division of HIV\/AIDS. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 269: 729-730, 1993.","DOI":"10.1001\/jama.269.6.729"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 327: 1643-1648, 1992.","DOI":"10.1056\/NEJM199212033272306"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Antinori A, Larussa D, Cingolani A, et al. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis 39: 1681-1691, 2004.","DOI":"10.1086\/424877"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Pradhan S, Yadav R, Mishra VN. Toxoplasma meningoencephalitis in HIV-seronegative patients: clinical patterns, imaging features and treatment outcome. Trans R Soc Trop Med Hyg 101: 25-33, 2007.","DOI":"10.1016\/j.trstmh.2006.02.021"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Parks NE, Goyal G, Go RS, Mandrekar J, Tobin WO. Neuroradiologic manifestations of Erdheim-Chester disease. Neurol Clin Pract 8: 15-20, 2018.","DOI":"10.1212\/CPJ.0000000000000422"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Cohen Aubart F, Idbaih A, Galanaud D, et al. Central nervous system involvement in Erdheim-Chester disease: an observational cohort study. Neurology 95: e2746-e2754, 2020.","DOI":"10.1212\/WNL.0000000000010748"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Boyd LC, O&apos;Brien KJ, Ozkaya N, et al. Neurological manifestations of Erdheim-Chester disease. Ann Clin Transl Neurol 7: 497-506, 2020.","DOI":"10.1002\/acn3.51014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cong W, Liu GH, Meng QF, et al. <i>Toxoplasma gondii<\/i> infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Lett 359: 307-313, 2015.","DOI":"10.1016\/j.canlet.2015.01.036"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Yazar S, Yaman O, Eser B, Altunta\u015f F, Kurnaz F, \u015eahin I. Investigation of anti-<i>Toxoplasma gondii<\/i> antibodies in patients with neoplasia. J Med Microbiol 53: 1183-1186, 2004.","DOI":"10.1099\/jmm.0.45587-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Israelski DM, Remington JS. Toxoplasmosis in patients with cancer. Clin Infect Dis 17: S423-S435, 1993.","DOI":"10.1093\/clinids\/17.Supplement_2.S423"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Savsek L, Opaskar TR. Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient. Radiol Oncol 50: 87-93, 2016.","DOI":"10.1515\/raon-2014-0042"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Herold MA, K\u00fchne R, Vosberg M, Ostheeren-Michaelis S, Vogt P, Karrer U. Disseminated toxoplasmosis in a patient with non-Hodgkin lymphoma. Infection 37: 551-554, 2009.","DOI":"10.1007\/s15010-009-9007-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Gay J, Gendron N, Verney C, et al. Disseminated toxoplasmosis associated with hemophagocytic syndrome after kidney transplantation: a case report and review. Transpl Infect Dis 21: e13154, 2019.","DOI":"10.1111\/tid.13154"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sanchez-Petitto G, Holtzman NG, Bukhari A, et al. <i>Toxoplasma<\/i>-induced hemophagocytic lymphohistiocytosis after haploidentical allogeneic stem cell transplantation. Transpl Infect Dis 22: e13242, 2020.","DOI":"10.1111\/tid.13242"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kator S, Zurko J, Webb BJ, et al. Disseminated toxoplasmosis and haemophagocytic lymphohistiocytosis following chimeric antigen receptor T-cell therapy. Br J Haematol 189: e4-e6, 2020.","DOI":"10.1111\/bjh.16402"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Cutini I, Gozzini A, Nozzoli C, et al. Toxoplasmosis-associated hemophagocytic lymphohistiocytosis in allogeneic transplantation. J Clin Immunol 41: 843-846, 2021.","DOI":"10.1007\/s10875-021-00979-8"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kara IO, Ergin M, Sahin B, Inal S, Tasova Y. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman&apos;s disease) previously misdiagnosed as <i>Toxoplasma<\/i> lymphadenitis. Leuk Lymphoma 45: 1037-1041, 2004.","DOI":"10.1080\/1042819031000149340"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Liao HJ, Chiang CW. <i>Toxoplasma<\/i> IgG expressed in a patient with Rosai-Dorfman disease. Kaohsiung J Med Sci 26: 373-376, 2010.","DOI":"10.1016\/S1607-551X(10)70061-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Sasai M, Pradipta A, Yamamoto M. Host immune responses to <i>Toxoplasma gondii<\/i>. Int Immunol 30: 113-119, 2018.","DOI":"10.1093\/intimm\/dxy004"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Drewry LL, Jones NG, Wang Q, Onken MD, Miller MJ, Sibley LD. The secreted kinase ROP17 promotes <i>Toxoplasma gondii<\/i> dissemination by hijacking monocyte tissue migration. Nat Microbiol 4: 1951-1963, 2019.","DOI":"10.1038\/s41564-019-0504-8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Milne P, Bigley V, Bacon CM, et al. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood 130: 167-175, 2017.","DOI":"10.1182\/blood-2016-12-757823"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/17\/61_8564-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T03:33:07Z","timestamp":1662175987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/17\/61_8564-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":27,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8564-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"article-number":"8564-21"}}